Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: HCC, . Treffer: 139

2022

Chao, X; Wang, S; Fulte, S; Ma, X; Ahamed, F; Cui, W; Liu, Z; Rülicke, T; Zatloukal, K; Zong, WX; Liu, W; Ni, HM; Ding, WX Hepatocytic p62 suppresses ductular reaction and tumorigenesis in mouse livers with mTORC1 activation and defective autophagy.
J Hepatol. 2022; 76(3):639-651 Doi: 10.1016/j.jhep.2021.10.014 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gkika, E; Grosu, AL; Macarulla, Mercade, T; Cubillo, Gracián, A; Brunner, TB; Schultheiß, M; Pazgan-Simon, M; Seufferlein, T; Touchefeu, Y Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study.
Cancers (Basel). 2022; 14(6): Doi: 10.3390/cancers14061568 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gufler, S; Seeboeck, R; Schatz, C; Haybaeck, J The Translational Bridge between Inflammation and Hepatocarcinogenesis.
Cells. 2022; 11(3): Doi: 10.3390/cells11030533 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Krstic, J; Reinisch, I; Schindlmaier, K; Galhuber, M; Riahi, Z; Berger, N; Kupper, N; Moyschewitz, E; Auer, M; Michenthaler, H; Nössing, C; Depaoli, MR; Ramadani-Muja, J; Usluer, S; Stryeck, S; Pichler, M; Rinner, B; Deutsch, AJA; Reinisch, A; Madl, T; Chiozzi, RZ; Heck, AJR; Huch, M; Malli, R; Prokesch, A Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism.
Sci Adv. 2022; 8(3):eabh2635 Doi: 10.1126/sciadv.abh2635 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Olbrich, A; Gros, O; Ebel, S; Denecke, T; Gößmann, H; Linder, N; Lordick, F; Forstmeyer, D; Seehofer, D; Sucher, R; Rademacher, S; Niemeyer, J; Matz-Soja, M; Berg, T; Bömmel, FV Dickkopf-Related Protein 1 as Response Marker for Transarterial Chemoembolization of Hepatocellular Carcinomas.
Cancers (Basel). 2022; 14(19): Doi: 10.3390/cancers14194807 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schemmer, P; Burra, P; Hu, RH; Hüber, CM; Loinaz, C; Machida, K; Vogel, A; Samuel, D State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post-liver transplantation and resection.
Liver Int. 2022; 42(2):288-298 Doi: 10.1111/liv.15124 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Seehofer, D; Sucher, R; Denecke, T [Resection and transplantation for hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
Radiologe. 2022; 62(3): 210-218. Doi: 10.1007/s00117-021-00962-9
Web of Science PubMed FullText FullText_MUG

 

2021

Bracic, Tomazic, S; Schatz, C; Haybaeck, J Translational Regulation in Hepatocellular Carcinogenesis.
Drug Des Devel Ther. 2021; 15: 4359-4369. Doi: 10.2147/DDDT.S255582 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Brunner, TB; Bettinger, D; Schultheiss, M; Maruschke, L; Sturm, L; Bartl, N; Koundurdjieva, I; Kirste, S; Neeff, HP; Goetz, C; Nicolay, NH; Ihorst, G; Bamberg, F; Thimme, R; Grosu, AL; Gkika, E Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study).
Front Oncol. 2021; 11: 653141 Doi: 10.3389/fonc.2021.653141 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rademacher, S; Aehling, NF; Sucher, R; Berg, T; Seehofer, D Current State and Future Possibilities in Liver Transplantation.
Surg Technol Int. 2021; 39:128-134 Doi: 10.52198/21.STI.39.TR1444
PubMed FullText FullText_MUG

 

Weitzer, F; Nazerani-Hooshmand, T; Aigner, RM; Pernthaler, B Different Appearances of 3 Malignancies in 68Ga-PSMA-11 Versus 18F-FDG PET/CT.
Clin Nucl Med. 2021; 46(7): e358-e359-e358-e359. Doi: 10.1097/RLU.0000000000003538
Web of Science PubMed FullText FullText_MUG

 

Zhang, F; Wang, Y; Chen, G; Li, Z; Xing, X; Putz-Bankuti, C; Stauber, RE; Liu, X; Madl, T Growing Human Hepatocellular Tumors Undergo a Global Metabolic Reprogramming.
Cancers (Basel). 2021; 13(8): Doi: 10.3390/cancers13081980 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Cubero, FJ; Mohamed, MR; Woitok, MM; Zhao, G; Hatting, M; Nevzorova, YA; Chen, C; Haybaeck, J; de Bruin, A; Avila, MA; Boekschoten, MV; Davis, RJ; Trautwein, C Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma.
Hepatol Commun. 2020; 4(6): 834-851. Doi: 10.1002/hep4.1495 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Morgul, MH; Felgendreff, P; Kienlein, A; Gauger, U; Semmling, K; Hau, HM; Tautenhahn, HM; Bartels, M Milan criteria in the MELD era-is it justifiable to extend the limits for orthotopic liver transplantation?
World J Surg Oncol. 2020; 18(1): 158 Doi: 10.1186/s12957-020-01932-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Nardo, AD; Grün, NG; Zeyda, M; Dumanic, M; Oberhuber, G; Rivelles, E; Helbich, TH; Markgraf, DF; Roden, M; Claudel, T; Trauner, M; Stulnig, TM Impact of osteopontin on the development of non-alcoholic liver disease and related hepatocellular carcinoma.
Liver Int. 2020; 40(7):1620-1633 Doi: 10.1111/liv.14464 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sladky, VC; Knapp, K; Szabo, TG; Braun, VZ; Bongiovanni, L; van den Bos, H; Spierings, DC; Westendorp, B; Curinha, A; Stojakovic, T; Scharnagl, H; Timelthaler, G; Tsuchia, K; Pinter, M; Semmler, G; Foijer, F; de Bruin, A; Reiberger, T; Rohr-Udilova, N; Villunger, A PIDDosome-induced p53-dependent ploidy restriction facilitates hepatocarcinogenesis.
EMBO Rep. 2020; 21(12):e50893-e50893 Doi: 10.15252/embr.202050893 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Stickel, F; Lutz, P; Buch, S; Nischalke, HD; Silva, I; Rausch, V; Fischer, J; Weiss, KH; Gotthardt, D; Rosendahl, J; Marot, A; Elamly, M; Krawczyk, M; Casper, M; Lammert, F; Buckley, TWM; McQuillin, A; Spengler, U; Eyer, F; Vogel, A; Marhenke, S; von Felden, J; Wege, H; Sharma, R; Atkinson, S; Franke, A; Nehring, S; Moser, V; Schafmayer, C; Spahr, L; Lackner, C; Stauber, RE; Canbay, A; Link, A; Valenti, L; Grove, JI; Aithal, GP; Marquardt, JU; Fateen, W; Zopf, S; Dufour, JF; Trebicka, J; Datz, C; Deltenre, P; Mueller, S; Berg, T; Hampe, J; Morgan, MY Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers.
Hepatology. 2020; 72(1):88-102 Doi: 10.1002/hep.30996 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Bettinger, D; Pinato, DJ; Schultheiss, M; Sharma, R; Rimassa, L; Pressiani, T; Burlone, ME; Pirisi, M; Kudo, M; Park, JW; Buettner, N; Neumann-Haefelin, C; Boettler, T; Abbasi-Senger, N; Alheit, H; Baus, W; Blanck, O; Gerum, S; Guckenberger, M; Habermehl, D; Ostheimer, C; Riesterer, O; Tamihardja, J; Grosu, AL; Thimme, R; Brunner, TB; Gkika, E Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis.
Liver Cancer. 2019; 8(4):281-294 Doi: 10.1159/000490260 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Chuong, MD; Kaiser, A; Khan, F; Parikh, P; Ben-Josef, E; Crane, C; Brunner, T; Okumura, T; Schreuder, N; Bentzen, SM; Gutierrez, A; Mendez, Romero, A; Yoon, SM; Sharma, N; Kim, TH; Kishi, K; Moeslein, F; Hoffe, S; Schefter, T; Hanish, S; Scorsetti, M; Apisarnthanarax, S Consensus Report From the Miami Liver Proton Therapy Conference.
Front Oncol. 2019; 9:457 Doi: 10.3389/fonc.2019.00457 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Czepukojc, B; Abuhaliema, A; Barghash, A; Tierling, S; Nass, N; Simon, Y; Korbel, C; Cadenas, C; van Hul, N; Sachinidis, A; Hengstler, JG; Helms, V; Laschke, MW; Walter, J; Haybaeck, J; Leclercq, I; Kiemer, AK; Kessler, SM IGF2 mRNA Binding Protein 2 Transgenic Mice Are More Prone to Develop a Ductular Reaction and to Progress Toward Cirrhosis
FRONT MED-LAUSANNE. 2019; 6: 179 Doi: 10.3389/fmed.2019.00179 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Denk, H; Stumptner, C; Abuja, PM; Zatloukal, K Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma.
Expert Opin Ther Targets. 2019; 23(5):393-406 Doi: 10.1080/14728222.2019.1601703
Web of Science PubMed FullText FullText_MUG

 

Gkika, E; Strouthos, I; Kirste, S; Adebahr, S; Schultheiss, M; Bettinger, D; Fritsch, R; Brass, V; Maruschke, L; Neeff, HP; Lang, SA; Nestle, U; Grosu, AL; Brunner, TB Repeated SBRT for in- and out-of-field recurrences in the liver.
Strahlenther Onkol. 2019; 195(3):246-253 Doi: 10.1007/s00066-018-1385-0
Web of Science PubMed FullText FullText_MUG

 

Golob-Schwarzl, N; Bettermann, K; Mehta, AK; Kessler, SM; Unterluggauer, J; Krassnig, S; Kojima, K; Chen, X; Hoshida, Y; Bardeesy, NM; Müller, H; Svendova, V; Schimek, MG; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Stojakovic, T; Nilsson, KPR; Kolbe, T; Rülicke, T; Magin, TM; Strnad, P; Kiemer, AK; Moriggl, R; Haybaeck, J High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype.
Transl Oncol. 2019; 12(2):256-268 Doi: 10.1016/j.tranon.2018.10.010 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Herden, U; Schoening, W; Pratschke, J; Manekeller, S; Paul, A; Linke, R; Lorf, T; Lehner, F; Braun, F; Stippel, DL; Sucher, R; Schmidt, H; Strassburg, CP; Guba, M; van, Rosmalen, M; Rogiers, X; Samuel, U; Schön, GM; Nashan, B Accuracy of Pretransplant Imaging Diagnostic for Hepatocellular Carcinoma: A Retrospective German Multicenter Study.
Can J Gastroenterol Hepatol. 2019; 2019:8747438 Doi: 10.1155/2019/8747438 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kern, B; Feurstein, B; Fritz, J; Fabritius, C; Sucher, R; Graziadei, I; Bale, R; Tilg, H; Zoller, H; Newsome, P; Eschertzhuber, S; Margreiter, R; Öfner, D; Schneeberger, S High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
Eur J Gastroenterol Hepatol. 2019; 31(2):205-210 Doi: 10.1097/MEG.0000000000001270
Web of Science PubMed FullText FullText_MUG

 

Kröhler, T; Kessler, SM; Hosseini, K; List, M; Barghash, A; Patial, S; Laggai, S; Gemperlein, K; Haybaeck, J; Müller, R; Helms, V; Schulz, MH; Hoppstädter, J; Blackshear, PJ; Kiemer, AK The mRNA-binding Protein TTP/ZFP36 in Hepatocarcinogenesis and Hepatocellular Carcinoma.
Cancers (Basel). 2019; 11(11): Doi: 10.3390/cancers11111754 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lackner, C; Quagliata, L; Cross, W; Ribi, S; Heinimann, K; Paradiso, V; Quintavalle, C; Kovacova, M; Baumhoer, D; Piscuoglio, S; Terracciano, L; Kovac, M Convergent Evolution of Copy Number Alterations in Multi-Centric Hepatocellular Carcinoma.
SCI REP-UK. 2019; 9(1): 4611-4611. Doi: 10.1038/s41598-019-40843-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lokau, J; Schoeder, V; Haybaeck, J; Garbers, C Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma.
Cancers (Basel). 2019; 11(11): Doi: 10.3390/cancers11111704 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Apostolidis, L; Pfeiffenberger, J; Gotthardt, D; Radeleff, B; Mehrabi, A; Schemmer, P; Jager, D; Schirmacher, P; Stremmel, W; Schulze-Bergkamen, H; Springfeld, C; Weiss, KH Survival of Hepatocellular Carcinoma Patients Treated with Sorafenib beyond Progression
GASTROINTEST TUMORS. 2018; 5(1-2): 38-46. Doi: 10.1159/000487635 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Bettinger, D; Gkika, E; Schultheiss, M; Glaser, N; Lange, S; Maruschke, L; Buettner, N; Kirste, S; Nestle, U; Grosu, AL; Thimme, R; Brunner, TB Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis.
BMC Cancer. 2018; 18(1):807 Doi: 10.1186/s12885-018-4696-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Filali Bouami, S; Gwiasda, J; Beneke, J; Kaltenborn, A; Liersch, S; Suero, EM; Koch, HF; Krauth, C; Klempnauer, J; Schrem, H Prognostic factors for long-term survival after adult liver transplantation.
Langenbecks Arch Surg. 2018; 403(4): 495-508. Doi: 10.1007/s00423-018-1670-5
Web of Science PubMed FullText FullText_MUG

 

Gkika, E; Bettinger, D; Krafft, L; Schultheiss, M; Neeff, HP; Maruschke, L; Schulenburg, M; Adebahr, S; Kirste, S; Nestle, U; Thimme, R; Grosu, AL; Brunner, TB The role of albumin-bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy.
Strahlenther Onkol. 2018; 194(5):403-413 Doi: 10.1007/s00066-017-1256-0
Web of Science PubMed FullText FullText_MUG

 

Heits, N; Brosch, M; Herrmann, A; Behrens, R; Röcken, C; Schrem, H; Kaltenborn, A; Klempnauer, J; Kreipe, HH; Reichert, B; Lenschow, C; Wilms, C; Vogel, T; Wolters, H; Wardelmann, E; Seehofer, D; Buch, S; Zeissig, S; Pannach, S; Raschzok, N; Dietel, M; von Schoenfels, W; Hinz, S; Teufel, A; Evert, M; Franke, A; Becker, T; Braun, F; Hampe, J; Schafmayer, C Evolutionary Distance Predicts Recurrence After Liver Transplantation in Multifocal Hepatocellular Carcinoma.
Transplantation. 2018; 102(10): e424-e430-e424-e430. Doi: 10.1097/TP.0000000000002356 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kozbial, K; Moser, S; Al-Zoairy, R; Schwarzer, R; Datz, C; Stauber, R; Laferl, H; Strasser, M; Beinhardt, S; Stättermayer, AF; Gschwantler, M; Zoller, H; Maieron, A; Graziadei, I; Trauner, M; Steindl-Munda, P; Hofer, H; Ferenci, P Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment.
Liver Int. 2018; 38(6):1028-1035 Doi: 10.1111/liv.13629 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Krstic, J; Galhuber, M; Schulz, TJ; Schupp, M; Prokesch, A p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine.
Int J Mol Sci. 2018; 19(3): Doi: 10.3390/ijms19030921 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Li, M; Su, Y; Zhang, F; Chen, K; Xu, X; Xu, L; Zhou, J; Wang, W A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy.
Acta Biomater. 2018; 75(10):413-426 Doi: 10.1016/j.actbio.2018.05.049
Web of Science PubMed FullText FullText_MUG

 

Piros, L; Máthé, Z [Laparoscopy in liver surgery].
Magy Onkol. 2018; 62(1):37-44 [OPEN ACCESS]
PubMed

 

Qu, Z; Ling, Q; Gwiasda, J; Xu, X; Schrem, H; Beneke, J; Kaltenborn, A; Krauth, C; Mix, H; Klempnauer, J; Emmanouilidis, N Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany.
Langenbecks Arch Surg. 2018; 403(5): 643-654. Doi: 10.1007/s00423-018-1696-8
Web of Science PubMed FullText FullText_MUG

 

Schaub, SK; Hartvigson, PE; Lock, MI; Høyer, M; Brunner, TB; Cardenes, HR; Dawson, LA; Kim, EY; Mayr, NA; Lo, SS; Apisarnthanarax, S Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies.
Technol Cancer Res Treat. 2018; 17:1533033818790217 Doi: 10.1177/1533033818790217 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Seitz, HK; Bataller, R; Cortez-Pinto, H; Gao, B; Gual, A; Lackner, C; Mathurin, P; Mueller, S; Szabo, G; Tsukamoto, H Alcoholic liver disease.
Nat Rev Dis Primers. 2018; 4(1):16-16 Doi: 10.1038/s41572-018-0014-7
Web of Science PubMed FullText FullText_MUG

 

Sunderkötter, CH; Zelger, B; Chen, KR; Requena, L; Piette, W; Carlson, JA; Dutz, J; Lamprecht, P; Mahr, A; Aberer, E; Werth, VP; Wetter, DA; Kawana, S; Luqmani, R; Frances, C; Jorizzo, J; Watts, JR; Metze, D; Caproni, M; Alpsoy, E; Callen, JP; Fiorentino, D; Merkel, PA; Falk, RJ; Jennette, JC Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.
Arthritis Rheumatol. 2018; 70(2):171-184 Doi: 10.1002/art.40375 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Aigelsreiter, A; Neumann, J; Pichler, M; Halasz, J; Zatloukal, K; Berghold, A; Douschan, P; Rainer, F; Stauber, R; Haybaeck, J; Denk, H; Lackner, C Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis.
Liver Int. 2017; 37(4):600-610 Doi: 10.1111/liv.13325
Web of Science PubMed FullText FullText_MUG

 

Bettinger, D; Spode, R; Glaser, N; Buettner, N; Boettler, T; Neumann-Haefelin, C; Brunner, TB; Gkika, E; Maruschke, L; Thimme, R; Schultheiss, M Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.
BMC Gastroenterol. 2017; 17(1):98 Doi: 10.1186/s12876-017-0656-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Boege, Y; Malehmir, M; Healy, ME; Bettermann, K; Lorentzen, A; Vucur, M; Ahuja, AK; Böhm, F; Mertens, JC; Shimizu, Y; Frick, L; Remouchamps, C; Mutreja, K; Kähne, T; Sundaravinayagam, D; Wolf, MJ; Rehrauer, H; Koppe, C; Speicher, T; Padrissa-Altés, S; Maire, R; Schattenberg, JM; Jeong, JS; Liu, L; Zwirner, S; Boger, R; Hüser, N; Davis, RJ; Müllhaupt, B; Moch, H; Schulze-Bergkamen, H; Clavien, PA; Werner, S; Borsig, L; Luther, SA; Jost, PJ; Weinlich, R; Unger, K; Behrens, A; Hillert, L; Dillon, C; Di Virgilio, M; Wallach, D; Dejardin, E; Zender, L; Naumann, M; Walczak, H; Green, DR; Lopes, M; Lavrik, I; Luedde, T; Heikenwalder, M; Weber, A A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development.
Cancer Cell. 2017; 32(3):342-359 Doi: 10.1016/j.ccell.2017.08.010 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Cătană, CS; Pichler, M; Giannelli, G; Mader, RM; Berindan-Neagoe, I Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma.
Oncotarget. 2017; 8(17):29519-29534 Doi: 10.18632/oncotarget.15706 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dengler, M; Staufer, K; Huber, H; Stauber, R; Bantel, H; Weiss, KH; Starlinger, P; Pock, H; Klöters-Plachky, P; Gotthardt, DN; Rauch, P; Lackner, C; Stift, J; Brostjan, C; Gruenberger, T; Kumada, T; Toyoda, H; Tada, T; Weiss, TS; Trauner, M; Mikulits, W Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Oncotarget. 2017; 8(28):46234-46248 Doi: 10.18632/oncotarget.17598 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ganten, TM; Stauber, RE; Schott, E; Malfertheiner, P; Buder, R; Galle, PR; Göhler, T; Walther, M; Koschny, R; Gerken, G Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study.
Clin Cancer Res. 2017; 23(19):5720-5728 Doi: 10.1158/1078-0432.CCR-16-0919 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gkika, E; Schultheiss, M; Bettinger, D; Maruschke, L; Neeff, HP; Schulenburg, M; Adebahr, S; Kirste, S; Nestle, U; Thimme, R; Grosu, AL; Brunner, TB Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma.
Radiat Oncol. 2017; 12(1):116 Doi: 10.1186/s13014-017-0851-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gkika, E; Tanadini-Lang, S; Kirste, S; Holzner, PA; Neeff, HP; Rischke, HC; Reese, T; Lohaus, F; Duma, MN; Dieckmann, K; Semrau, R; Stockinger, M; Imhoff, D; Kremers, N; Häfner, MF; Andratschke, N; Nestle, U; Grosu, AL; Guckenberger, M; Brunner, TB Interobserver variability in target volume delineation of hepatocellular carcinoma : An analysis of the working group "Stereotactic Radiotherapy" of the German Society for Radiation Oncology (DEGRO).
Strahlenther Onkol. 2017; 193(10):823-830 Doi: 10.1007/s00066-017-1177-y
Web of Science PubMed FullText FullText_MUG

 

Golob-Schwarzl, N; Krassnig, S; Toeglhofer, AM; Park, YN; Gogg-Kamerer, M; Vierlinger, K; Schröder, F; Rhee, H; Schicho, R; Fickert, P; Haybaeck, J New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors.
Eur J Cancer. 2017; 83(60):56-70 Doi: 10.1016/j.ejca.2017.06.003
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum